MedPath
Found 7 clinical trials|View Analysis
Sort by:

Nipocalimab in Moderate to Severe Sjogren's Disease

Phase 3
Recruiting
Conditions
Sjogrens Syndrome
Interventions
Drug: Placebo
Drug: Nipocalimab
Drug: Standard of care treatment
First Posted Date
2024-12-19
Last Posted Date
2024-12-19
Lead Sponsor
Janssen Research & Development, LLC
Target Recruit Count
600
Registration Number
NCT06741969
Locations
🇺🇸

Inland Rheumatology Clinical Trials Inc., Upland, California, United States

🇺🇸

Clinical Investigation Specialists - Clinic of Robert Hozman, Skokie, Illinois, United States

🇺🇸

Altoona Center For Clinical Research, Duncansville, Pennsylvania, United States

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

Phase 3
Recruiting
Conditions
Sjogrens Syndrome
Interventions
First Posted Date
2023-08-14
Last Posted Date
2024-12-20
Lead Sponsor
Novartis Pharmaceuticals
Target Recruit Count
600
Registration Number
NCT05985915
Locations
🇺🇸

North GA Rheumatology Group PC, Duluth, Georgia, United States

🇺🇸

University of Kansas Hospital, Kansas City, Kansas, United States

🇺🇸

STAT Research Inc, Dayton, Ohio, United States

and more 22 locations

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

Phase 3
Recruiting
Conditions
Sjögren's Syndrome
Interventions
Drug: Deucravacitinib
Other: Placebo
First Posted Date
2023-07-14
Last Posted Date
2025-01-08
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
756
Registration Number
NCT05946941
Locations
🇺🇸

Arthritis and Osteoporosis Medical Center, La Palma, California, United States

🇧🇬

ARENSIA Research Clinic MBAL Sveta Sofia, Sofia, Bulgaria

🇨🇦

University Health Network - Toronto Western Hospital, Toronto, Ontario, Canada

and more 220 locations

Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome

Phase 3
Completed
Conditions
Dry Eye
Interventions
First Posted Date
2020-07-14
Last Posted Date
2020-07-14
Lead Sponsor
Federal University of São Paulo
Target Recruit Count
32
Registration Number
NCT04470479
Locations
🇧🇷

Irmandade Santa casa de Misericórdia de São Paulo, São Paulo, Brazil

Fecal Microbial Transplant (FMT) for Sjogrens Syndrome

Phase 1
Completed
Conditions
Sjogren's Syndrome
Interventions
Drug: FMP-30
First Posted Date
2019-04-24
Last Posted Date
2020-06-05
Lead Sponsor
University of Miami
Target Recruit Count
10
Registration Number
NCT03926286
Locations
🇺🇸

University of Miami, Miami, Florida, United States

Sjogrens Syndrome Measured by Ultrasound

Phase 2
Conditions
Sjogren's Syndrome
Interventions
Other: Placebo
Biological: Orencia
First Posted Date
2018-01-26
Last Posted Date
2021-05-11
Lead Sponsor
Arthritis & Rheumatism Associates, P.C.
Target Recruit Count
20
Registration Number
NCT03411850
Locations
🇺🇸

The Center for Rheumatology and Bone Research a division of Arthritis and Rheumatism Associates, P.C., Wheaton, Maryland, United States

A Study of Flt3-Ligand Levels in Sjögrens Syndrome

Completed
Conditions
Sjogrens Syndrome
First Posted Date
2011-11-11
Last Posted Date
2019-04-24
Lead Sponsor
Göteborg University
Target Recruit Count
30
Registration Number
NCT01470638
Locations
🇸🇪

Dept of Rheumatology, Sahlgrenska University Hospital, Gothenburg, Sweden

© Copyright 2025. All Rights Reserved by MedPath